• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有青紫型先天性心脏病的儿科患者中的儿茶酚胺分泌肿瘤

Catecholamine-Secreting Tumors in Pediatric Patients With Cyanotic Congenital Heart Disease.

作者信息

Agarwal Swashti, Jindal Ishita, Balazs Andrea, Paul David

机构信息

Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.

出版信息

J Endocr Soc. 2019 Sep 5;3(11):2135-2150. doi: 10.1210/js.2019-00226. eCollection 2019 Nov 1.

DOI:10.1210/js.2019-00226
PMID:31687640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6821216/
Abstract

Catecholamine-secreting tumors are rare among the pediatric population but are increasingly being reported in children with sustained hypoxia secondary to cyanotic congenital heart disease (CCHD). With this review, we report the clinical characteristics of these tumors in children with CCHD. The articles included in the present review were identified using PubMed through February 2019. A manual search of the references retrieved from relevant articles was also performed. Pheochromocytomas and paragangliomas (PPGL) in children are commonly associated with high-risk germline or somatic mutations. There is evidently a higher risk of tumorigenesis in children with CCHD as compared with the general pediatric population, even in the absence of susceptible gene mutations. This is due to molecular mechanisms involving the aberrant activation of hypoxia-response elements, likely secondary to sustained hypoxemia, resulting in tumorigenesis. Due to overlapping symptoms with CCHD, the diagnosis of PPGL may be delayed or missed in these patients. We studied all previously reported PPGL cases in children with CCHD and reviewed phenotypic and biochemical features to assess for contributing factors in tumorigenesis. Larger studies are needed to help determine other potential predisposing factors and to establish screening guidelines in this high-risk population. A delay in diagnosis of the PPGL tumors can lead to exacerbation of cardiac failure, and therefore early diagnosis and intervention may provide better outcomes in these patients, necessitating the need for regular surveillance. We recommend routine biochemical screening in patients with sustained hypoxia secondary to CCHD.

摘要

儿茶酚胺分泌性肿瘤在儿科人群中较为罕见,但在患有因青紫型先天性心脏病(CCHD)继发的持续性缺氧的儿童中报告越来越多。通过本综述,我们报告了这些肿瘤在患有CCHD的儿童中的临床特征。本综述纳入的文章通过PubMed检索至2019年2月。还对从相关文章中检索到的参考文献进行了人工检索。儿童嗜铬细胞瘤和副神经节瘤(PPGL)通常与高风险的种系或体细胞突变相关。与普通儿科人群相比,患有CCHD的儿童即使在没有易感基因突变的情况下,肿瘤发生风险显然更高。这是由于涉及缺氧反应元件异常激活的分子机制,可能继发于持续性低氧血症,从而导致肿瘤发生。由于与CCHD症状重叠,这些患者中PPGL的诊断可能会延迟或漏诊。我们研究了所有先前报道的患有CCHD的儿童中的PPGL病例,并回顾了表型和生化特征以评估肿瘤发生的促成因素。需要更大规模的研究来帮助确定其他潜在的易感因素,并在这个高风险人群中建立筛查指南。PPGL肿瘤诊断延迟可导致心力衰竭加重,因此早期诊断和干预可能为这些患者带来更好的结局,这就需要进行定期监测。我们建议对患有因CCHD继发的持续性缺氧的患者进行常规生化筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/736e88ede797/js.2019-00226f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/827e42c77312/js.2019-00226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/a45d2b6204ee/js.2019-00226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/1b8d29ff1a65/js.2019-00226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/2b4cf95eb359/js.2019-00226f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/736e88ede797/js.2019-00226f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/827e42c77312/js.2019-00226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/a45d2b6204ee/js.2019-00226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/1b8d29ff1a65/js.2019-00226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/2b4cf95eb359/js.2019-00226f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c903/6821216/736e88ede797/js.2019-00226f5.jpg

相似文献

1
Catecholamine-Secreting Tumors in Pediatric Patients With Cyanotic Congenital Heart Disease.患有青紫型先天性心脏病的儿科患者中的儿茶酚胺分泌肿瘤
J Endocr Soc. 2019 Sep 5;3(11):2135-2150. doi: 10.1210/js.2019-00226. eCollection 2019 Nov 1.
2
Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.合并发绀型先天性心脏病的嗜铬细胞瘤和副神经节瘤的遗传学分析。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2545-2555. doi: 10.1210/clinem/dgac362.
3
Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.先天性发绀型心脏病与嗜铬细胞瘤和副神经节瘤的关系。
Curr Cardiol Rep. 2023 Nov;25(11):1451-1460. doi: 10.1007/s11886-023-01974-8. Epub 2023 Oct 17.
4
Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.青紫型和非青紫型先天性心脏病患者血浆代谢产物的比较。
Endocrine. 2022 Dec;78(3):580-586. doi: 10.1007/s12020-022-03205-6. Epub 2022 Oct 4.
5
Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.青紫型先天性心脏病中的嗜铬细胞瘤和副神经节瘤
J Clin Endocrinol Metab. 2015 Apr;100(4):1325-34. doi: 10.1210/jc.2014-3863. Epub 2015 Jan 12.
6
Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.嗜铬细胞瘤-副神经节瘤与青紫型先天性心脏病并存:一例报告及文献综述
Front Endocrinol (Lausanne). 2018 Apr 17;9:165. doi: 10.3389/fendo.2018.00165. eCollection 2018.
7
Anaesthetic Management of Secretory Paraganglioma With Cyanotic Heart Disease: Double Trouble.伴有青紫型心脏病的分泌性副神经节瘤的麻醉管理:双重难题。
Cureus. 2022 May 25;14(5):e25328. doi: 10.7759/cureus.25328. eCollection 2022 May.
8
An EGLN1 mutation may regulate hypoxic response in cyanotic congenital heart disease through the PHD2/HIF-1A pathway.EGLN1突变可能通过PHD2/HIF-1A途径调节紫绀型先天性心脏病中的缺氧反应。
Genes Dis. 2018 Mar 13;6(1):35-42. doi: 10.1016/j.gendis.2018.03.003. eCollection 2019 Mar.
9
Pheochromocytoma in Congenital Cyanotic Heart Disease.先天性青紫型心脏病中的嗜铬细胞瘤
Case Rep Endocrinol. 2018 Sep 25;2018:2091257. doi: 10.1155/2018/2091257. eCollection 2018.
10
[Assessment of undiagnosed critical congenital heart disease before discharge from the maternity hospital].[产院出院前未诊断出的严重先天性心脏病评估]
Zhonghua Er Ke Za Zhi. 2017 Apr 2;55(4):260-266. doi: 10.3760/cma.j.issn.0578-1310.2017.04.006.

引用本文的文献

1
HIF and MYC signaling in adrenal neoplasms of the neural crest: implications for pediatrics.神经嵴来源肾上腺肿瘤中的 HIF 和 MYC 信号通路:对儿科的影响。
Front Endocrinol (Lausanne). 2023 Jun 8;14:1022192. doi: 10.3389/fendo.2023.1022192. eCollection 2023.
2
Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.卡尼三联征、卡尼-斯特拉塔斯基综合征、3PAS 和其他因 SDH 缺陷引起的肿瘤。
Front Endocrinol (Lausanne). 2021 May 3;12:680609. doi: 10.3389/fendo.2021.680609. eCollection 2021.

本文引用的文献

1
The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma.68Ga-DOTA-Octreotate PET/CT 在 SDH 相关嗜铬细胞瘤和副神经节瘤随访中的作用。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5091-5099. doi: 10.1210/jc.2019-00018.
2
Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.临床实践指南:琥珀酸脱氢酶基因突变携带者的嗜铬细胞瘤和副神经节瘤监测。
Clin Endocrinol (Oxf). 2019 Apr;90(4):499-505. doi: 10.1111/cen.13926. Epub 2019 Jan 29.
3
Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected.
法洛四联症患者的嗜铬细胞瘤和副神经节瘤:比预期更常见。
Congenit Heart Dis. 2018 Jul;13(4):608-616. doi: 10.1111/chd.12625. Epub 2018 Jul 22.
4
Performance of Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis.镓-DOTA 偶联生长抑素受体靶向肽 PET 在嗜铬细胞瘤和副神经节瘤检测中的性能:系统评价和荟萃分析。
J Nucl Med. 2019 Mar;60(3):369-376. doi: 10.2967/jnumed.118.211706. Epub 2018 Jul 20.
5
Retroperitoneal paraganglioma in a patient with Fontan: The hypoxia connection.一名接受Fontan手术患者的腹膜后副神经节瘤:与缺氧的关联。
Ann Pediatr Cardiol. 2018 May-Aug;11(2):197-200. doi: 10.4103/apc.APC_172_17.
6
EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease.青紫型先天性心脏病中的EPAS1突变与副神经节瘤
N Engl J Med. 2018 Mar 29;378(13):1259-1261. doi: 10.1056/NEJMc1716652.
7
A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2 positive polycythemia vera: a case report.患者患有嗜铬细胞瘤和 JAK2 阳性红细胞增多症,存在 IRP1 剪接位点新型体细胞突变:病例报告。
BMC Cancer. 2018 Mar 13;18(1):286. doi: 10.1186/s12885-018-4127-x.
8
Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review.荷兰嗜铬细胞瘤和副神经节瘤的发病率:一项全国性研究和系统评价。
Eur J Intern Med. 2018 May;51:68-73. doi: 10.1016/j.ejim.2018.01.015. Epub 2018 Feb 1.
9
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.嗜铬细胞瘤和副神经节瘤的综合分子特征
Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.
10
Pheochromocytoma complicated by cyanotic congenital heart disease: a case report.嗜铬细胞瘤合并青紫型先天性心脏病:一例报告
Clin Pediatr Endocrinol. 2016 Apr;25(2):59-65. doi: 10.1297/cpe.25.59. Epub 2016 Apr 28.